Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Figures and Graphics
Grunert S et al.  
Intracoronary and Intravenous Magnesium Does Not Reduce Myocardial Infarct Size in a Canine Model of Regional Ischaemia and Reperfusion

Journal of Clinical and Basic Cardiology 2002; 5 (1): 23-28

PDF    Summary    Figures   


Figure
 
Magnesium - intrakoronar - intravenös
Figure 1: Experimental preparation and protocol of intracoronary magnesium (A) and intravenous magnesium (B) (time in min)


Keywords: Graphische DarstellungheartHerzmagnesiummagnesiummyocardiumMyokardprotocolProtokoll
 
 
Magnesium - Kalium - Serumkonzentration
Figure 2: Total serum concentration of magnesium and potassium during intravenous infusion of magnesium potassium aspartate or placebo. Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of reperfusion of the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or placebo was infused intravenously; values are means +/- SD


Keywords: AspartateConcentrationDiagrammInfusionInfusionKaliumKaliumaspartatKonzentrationmagnesiummagnesiumMagnesiumaspartatpotassiumSerumSerum
 
 
Magnesium - Linksventrikulärer Druck
Figure 3: Left ventricular pressure (LVP) during intracoronary magnesium aspartate use (A-upper panel) and intravenous magnesium potassium aspartate use (B-lower panel). Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of left anterior descending artery reperfusion; Mg i.c. = time period when magnesium aspartate or vehicle was infused into the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means +/- SD


Keywords: AspartateDiagrammDruckInfusionInfusionmagnesiummagnesiumMagnesiumaspartatpressureventricleVentrikel
 
 
Magnesium-Kalium-Aspartat - Herzfrequenz
Figure 4: Heart rate during administration of intravenous magnesium potassium aspartate in ischaemia-reperfusion. HR = heart rate; Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of reperfusion of the left anterior descending artery; Infusion i.v., time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means +/- SD; Mg2+-K+ vs Control; P < 0.001


Keywords: AspartateDiagrammheart rateHerzfrequenzKaliumKaliumaspartatmagnesiummagnesiumMagnesiumaspartatpotassium
 
 
Magnesium - Linksventrikulärer Druck
Figure 5A-B: A: Left ventricular pressure (LVP) during intravenous infusion of magnesium potassium aspartate or placebo. B: Regional wall function in the anterior (ischaemic) and posterior (non-ischaemic) wall during intracoronary infusion of magnesium aspartate or vehicle (A-upper panel) and intravenous infusion of magnesium potassium aspartate or vehicle (B-lower panel). WThSYS = systolic wall thickening; Occl. = time period of left anterior descending coronary artery occlusion; Reperfusion = time period of left anterior descending artery reperfusion; Mg i.c. = time period when magnesium aspartate or vehicle was infused into the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means ± SD


Keywords: AspartateDiagrammDruckInfusionInfusionKaliumKaliumaspartatmagnesiummagnesiumMagnesiumaspartatpotassiumpressureventricleVentrikelwall functionWandbewegung
 
 
Magnesium - Infarktgröße
Figure 6: Infarct size as percentage of area at risk after intracoronary magnesium aspartate or placebo and intravenous magnesium potassium aspartate or placebo; values are single values and means +/- SD (filled symbols)


Keywords: Aspartateinfarct sizeInfarktgrößemagnesiummagnesiumMagnesiumaspartatmyocardial infarctionMyokardinfarkt
 
 
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung